Welcome to our dedicated page for Core Scientific news (Ticker: CORZ), a resource for investors and traders seeking the latest updates and insights on Core Scientific stock.
Core Scientific, Inc. designs, builds and operates large-scale, purpose-built data centers for high-density colocation services serving AI-related workloads. Company news centers on data center campus development, power-capacity expansion, customer and partnership activity, and the ongoing shift from digital asset mining toward high-density colocation revenue.
Updates also cover Core Scientific’s remaining digital asset self-mining and hosted mining activities, financing actions used to support data center development, and operating results tied to its facilities in Alabama, Georgia, Kentucky, North Carolina, North Dakota, Oklahoma and Texas.
Core Scientific (NASDAQ: CORZ) reported Q4 2025 results: total revenue of $79.8M, colocation revenue of $31.3M, gross profit of $20.8M and net income of $216.0M. Capital expenditures were $279.2M, with $226.2M funded by CoreWeave.
The company disclosed a material restatement of prior periods due to improper capitalization of assets committed to demolition and will restate multiple 2024–2025 interim and annual periods.
Core Scientific (Nasdaq: CORZ) will release fourth quarter and fiscal year 2025 results after market close on Monday, March 2, 2026. Management will host a conference call and live audio webcast at 3:30 p.m. Central Time to discuss results.
Executives on the call include CEO Adam Sullivan, COO Matt Brown, CFO Jim Nygaard, and VP Investor Relations Jon Charbonneau. Investors can access the live webcast via the company Investor Relations website and an audio replay will be archived there.
Blockfusion (to trade via Blue Acquisition Corp, Nasdaq: BACC) will combine with Blue Acquisition to form Blockfusion Data Centers, Inc., reflecting a $450 million pre‑money equity value (implied $480 million enterprise value) and targeting a first‑half 2026 close. The company operates a clean energy‑powered Niagara Facility with 46 MW energized today and plans to expand to >100 MW of Tier 3 capacity supporting 200 kW per rack GPU workloads.
Blue Acquisition holds ~$204 million in trust; the deal aims to deliver ~$200 million to the go‑forward business via trust retention and PIPE. Management projects up to $128M revenue / $75M EBITDA by 2028 and $209M revenue / $132M EBITDA by 2030, excluding capital expenditures and contingent on capital access and customer offtake.
Tradr ETFs (Cboe: COZX) launched the Tradr 2X Long CORZ Daily ETF on Nov 5, 2025, seeking 200% daily exposure to Core Scientific (Nasdaq: CORZ). The fund is listed on Cboe and joins Tradr's AI-infrastructure suite.
Tradr reports a lineup of 49 leveraged ETFs representing over $2.2 billion AUM. The product targets sophisticated investors and short-term traders and emphasizes leverage risks, potential divergence from benchmark over periods longer than the reset, and the possibility of total loss if CORZ moves >50% adverse in one day.
Two Seas Capital (NASDAQ:CORZ) commented on the outcome of Core Scientific's special meeting held on October 30, 2025, where shareholders rejected the company's proposed sale to CoreWeave (NASDAQ:CRWV).
Two Seas, identified as one of Core Scientific's largest shareholders, thanked fellow shareholders for rejecting the transaction and reiterated confidence in Core Scientific's management and strategy. The statement urged focus on growing the power pipeline, securing additional contracts, and building next-generation data centers, and said Two Seas will work constructively with the company to pursue long-term value creation.
Core Scientific (Nasdaq: CORZ) will host an investor conference call and live audio webcast today, October 30, 2025, at 11:30 AM Eastern Time. Management participants include Adam Sullivan (CEO), Matt Brown (COO), Jim Nygaard (CFO) and Jon Charbonneau (VP, Investor Relations).
Investors can access the live webcast via the Investors section of Core Scientific’s website at https://investors.corescientific.com. An audio replay will be archived on the same investor relations page after the event.
Core Scientific (NASDAQ: CORZ) announced that a special meeting of stockholders failed to deliver the votes required to approve the previously announced merger agreement with CoreWeave, and, pursuant to the merger agreement, Core Scientific terminated the merger agreement effective October 30, 2025. The company said it will remain a publicly traded issuer and its common stock will continue to trade on Nasdaq under the ticker CORZ.
Core Scientific (Nasdaq: CORZ) announced on October 30, 2025 that at a special meeting of stockholders the company did not receive the requisite votes to approve its previously announced merger agreement with CoreWeave (Nasdaq: CRWV).
The company said the final voting results will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission.
Two Seas Capital (NASDAQ: CORZ) issued a letter on Oct 28, 2025 urging Core Scientific shareholders to vote AGAINST the proposed sale to CoreWeave (announced July 7, 2025). Two Seas says the deal values Core Scientific at $16.40 per share and argues that Core Scientific has materially higher standalone upside—claiming the stock would trade at more than twice the deal value if aligned with AI-infrastructure peers.
The letter highlights Core Scientific's access to low-cost power, operational expertise, and a 700-megawatt pipeline, and warns that approving the transaction would transfer value to CoreWeave. Shareholders face a vote at a special meeting on Oct 30, 2025.
Core Scientific (NASDAQ: CORZ) reported fiscal Q3 2025 results with total revenue $81.1M versus $95.4M a year earlier and gross profit $3.9M vs. a prior-year gross loss. Digital asset self-mining revenue fell to $57.4M, driven by a 55% decline in bitcoin mined despite an 88% higher average bitcoin price. High-density colocation revenue rose to $15.0M from $10.3M. Net loss narrowed to $146.7M from $455.3M, partly due to smaller non-cash fair-value adjustments. Adjusted EBITDA was a $2.4M loss. Q3 capital expenditures totaled $244.5M, of which $196.4M was funded by CoreWeave. Liquidity stood at $694.8M (cash $453.4M; bitcoin $241.4M). CoreWeave proposed an all-stock merger at an exchange ratio of 0.1235, with a stockholder vote scheduled for October 30, 2025.